|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/10 | (2006.01) |
| A61K 38/17 | (2006.01) | ||
| C07K 14/705 | (2006.01) |
| (11) | Number of the document | 2555789 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11718957.1 |
| Date of filing the European patent application | 2011-04-08 | |
| (97) | Date of publication of the European application | 2013-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-10 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (86) | Number | PCT/EP2011/055519 |
| Date | 2011-04-08 |
| (87) | Number | WO 2011/124685 |
| Date | 2011-10-13 |
| (30) | Number | Date | Country code |
| 10305364 | 2010-04-08 | EP |
| (72) |
GIBOT, Sébastien, FR
DERIVE, Marc, FR
|
| (73) |
Université de Lorraine,
34 Cours Léopold CS 25233, 54052 Nancy Cedex,
FR
INSERM (Institut National de la Santé et de la Recherche Médicale), 101, rue de Tolbiac, 75013 Paris, FR |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Inhibuojantys peptidai, kilę iš TREM tipo transkripto 1 (TLT-1), ir jų naudojimas |
| INHIBITING PEPTIDES DERIVED FROM TREM-LIKE TRANSCRIPT 1 (TLT-1) AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-03-24 | 15 | 289.00 EUR |
| 2026-04-08 |